https://www.selleckchem.com/pr....oducts/n-acetyl-dl-m
Decedents not receiving PCC had higher rates of no de-escalation of interventions at time of death (31% vs. 11%), indicating full intensive care measures continued through death. Among patients with COVID-19 receiving ECMO, PCC may be associated with a shift to DNAR status particularly with automatic PCC. There may be a further impact on length of stay, duration of time on ECMO and care plan at end of life. Among patients with COVID-19 receiving ECMO, PCC may be associated with a shift to DNAR status particularly with aut
Beğen
Yorum Yap
Paylaş
